MMR Uproar: Label Raises Moral Alarms

Pennsylvania’s governor claimed the MMR shot has “no fetal tissue,” but the federal label and medical guides confirm its rubella virus is grown in a human fetal-derived cell line.

Story Highlights

Governor Josh Shapiro said “There is no fetal tissue in the MMR.”
Federal labeling shows the rubella virus is grown in WI-38 human fetal-derived cells.
Medical guides say trace byproducts from WI-38 can remain after production.
Robert F. Kennedy Jr. highlighted the WI-38 origin in a public post.

What Shapiro Said And Why It Sparked Pushback

Governor Josh Shapiro told the public, “There is no fetal tissue in the MMR,” citing the American Academy of Pediatrics and arguing that warnings from Robert F. Kennedy Jr. fuel fear during measles outbreaks. He framed Kennedy’s remarks as harmful “misinformation,” saying such claims have real-world effects in his state. Shapiro’s message centers on what is inside the final vial, not how the product is made. His post amplified the “no fetal tissue” line for a wide audience.

Robert F. Kennedy Jr. responded by pointing to the production history of the rubella component in the MMR combination shot. He said the rubella virus used in MMR-II is grown using a cell line that started from lung tissue of an aborted three-month-old female embryo in the 1960s, known as WI-38. His post focused on the moral and sourcing issue, not only the content of the finished dose. That nuance triggered a broader debate online and in the press.

What The Federal Label And Ingredient Guides Actually Say

The United States Food and Drug Administration’s package insert for Measles, Mumps, and Rubella Virus Vaccine Live (M-M-R II) states the rubella virus is propagated in WI-38 human diploid lung fibroblasts. That means the virus is grown in a human fetal-derived cell line first created decades ago. The insert distinguishes growth medium from the final product, but it leaves no doubt about WI-38’s role in manufacturing the rubella component. This is the key factual point at issue.

The Children’s Hospital of Philadelphia’s vaccine-ingredient guide explains that small amounts of material from the manufacturing process can remain in the final dose. For MMR-II, it lists “proteins from cells used to grow virus (WI-38 human cells)” among residual byproducts, along with recombinant human albumin, fetal bovine serum, and neomycin. This supports the claim that the rubella virus is produced using a fetal-derived cell line and that trace byproducts can carry through after purification.

Where The Two Sides Agree And Disagree

Both sides agree that no one is putting intact fetal tissue into the vial. The dispute turns on wording. Shapiro stresses the final shot does not contain “fetal tissue.” Kennedy stresses that the rubella virus is produced using a fetal-derived cell line. Medical explainers back the production fact while clarifying that present-day lots use descendants of cells from the 1960s, not new abortions. Readers should separate content claims from sourcing claims to see the full picture.

For many faith-minded Americans, the origin matters. The use of a cell line that began with an abortion raises moral concerns even if purification reduces the end product to virus and trace byproducts. The debate is not about whether measles is serious. It is about informed consent, clear labels, and respect for conscience. Transparent language from officials would help parents make choices without being told that facts about manufacturing are out of bounds.

What Parents Should Know Right Now

Federal labeling ties the rubella component of MMR-II to WI-38 human fetal-derived cells. Ingredient guides say trace byproducts from those cells can remain. At the same time, the final vaccine does not include intact fetal tissue. These facts can all be true at once. Honest debate should reflect that. Leaders serve families best when they admit trade-offs, respect religious liberty, and present facts without spin—especially during outbreaks when trust is crucial.